This is a combined synopsis/solicitation from the NIH for software license renewals, but it is a notice of intent to award a sole-source contract to Azenta US, Inc. in Indianapolis, IN. The contract is for the renewal of two specific software support licenses for the Undiagnosed Diseases Program: an On Premise Limfinity Platform license and a FreezerPro On Premise Support license. The performance periods are from June 1, 2026, to May 31, 2027, for the Limfinity license and from July 27, 2026, to July 26, 2027, for the FreezerPro support. The notice explicitly states this is not a request for competitive quotations, as the government intends to negotiate with only the one source.

This is a notice of a sole-source intent to contract with Azenta US, Inc. for software license renewals for the NIH Undiagnosed Diseases Program. The required services are for the On Premise Limfinity Platform (UDPics) and FreezerPro On Premise Support. The period of performance for the Limfinity license is from June 1, 2026, through May 31, 2027, and for the FreezerPro license from July 27, 2026, through July 26, 2027. The justification is that Azenta is the developer and sole provider of these specific applications. While the notice states it is not a request for competitive quotations, it indicates all responsible sources may submit a quotation for consideration.